Company news

Bio-Techne Corp news in 2023

Bio-Techne Corp's news releases, calls and decks from 2023, newest first.

View company

Bio-Techne to present at the 42nd annual j.p. morgan healthcare conference

December 20, 2023

Bio-Techne announces submission of FDA Drug Master File for ExCellerate GMP iPSC Expansion Medium supporting stem cell therapy

December 19, 2023

Bio-Techne to present at the 6th annual evercore isi healthconx conference

November 26, 2023

Asuragen to present novel clinical testing data at AMP 2023 conference

November 1, 2023

Bio-Techne releases first quarter fiscal 2024 results

October 30, 2023

Leading research institutes to present new data using Lunaphore's COMET™ technology at the society for immunotherapy of cancer (sitc) 38th annual meeting

October 24, 2023

Bio-Techne appoints Kim Kelderman as Chief Executive Officer

October 18, 2023

Bio-Techne achieves ISO 13485 certification for its Wallingford, ct manufacturing facility

October 15, 2023

Bio-Techne to host conference call on October 31, 2023, to announce first quarter fiscal 2024 financial results

October 9, 2023

Dr. Jordan Laser awarded AMP meritorious service award

September 27, 2023

SCIENTISTS AT CE PHARM CONFERENCE DESCRIBE HOW Maurice™ AND MauriceFlex™ SYSTEMS TRANSFORM THEIR PROTEIN ANALYSIS

September 26, 2023

Bio-Techne integrates its Maurice system with the thermo scientific chromeleon chromatography data system

September 25, 2023

Bio-Techne issues 2023 corporate sustainability report

September 24, 2023

Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western™ Platform

September 18, 2023

Bio-Techne announces 2023 Investor Day and webcast

August 23, 2023

Bio-Techne to present at the ubs medtech, tools and Genomics Summit 2023

August 14, 2023

Bio-Techne ends collaboration program with Akoya to automate RNAscope on the phenocycler fusion

August 13, 2023

Bio-Techne releases fourth quarter fiscal 2023 results

August 7, 2023

Bio-Techne to host conference call on August 8, 2023, to announce fourth quarter and fiscal 2023 financial results

July 12, 2023

Bio-Techne completes Lunaphore acquisition

July 9, 2023

Bio-Techne to acquire Lunaphore

June 21, 2023

Bio-Techne successful on claim of reverse engineering by Miltenyi biotec

May 31, 2023

Bio-Techne to present at the 2023 jefferies healthcare conference

May 24, 2023

Exosome Diagnostics releases interim results from clinical study of prostate cancer risk Test

May 17, 2023

Bio-Techne commercializes RNAscope spatial biology workflow for the Standard BioTools Hyperion Imaging System

May 15, 2023

Bio-Techne to present at the 2023 rbc capital markets global healthcare conference

May 11, 2023

BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA

May 9, 2023

Bio-Techne releases third quarter fiscal 2023 results

May 2, 2023

Bio-Techne to present at the bofa securities 2023 health care conference

May 1, 2023

Bio-Techne and Lunaphore establish strategic partnership to develop the first fully automated same-slide spatial multiomics solution

April 16, 2023

Bio-Techne to showcase innovative cancer research, cell therapy and manufacturing tools at aacr 2023 conference

April 12, 2023

Bio-Techne to host conference call on May 3, 2023, to announce third quarter 2023 financial results

April 11, 2023

Bio-Techne celebrates milestone with more than 1,000 Ella™ instruments now in operation

April 4, 2023

Bio-Techne completes investment in Wilson Wolf Manufacturing

April 2, 2023

Bio-Techne announces completion of Cell and Gene Therapy Catapult process analytical technology (PAT) consortium

March 14, 2023

Bio-Techne to present at the barclays global healthcare conference

March 9, 2023

Bio-Techne announces investment in Wilson Wolf

February 28, 2023

Bio-Techne to present at the cowen 43rd annual health care conference

February 27, 2023

ExoDx PROSTATE TEST GRANTED EXPANDED COVERAGE BY MEDICARE

February 23, 2023

Bio-Techne to present at the citi 2023 healthcare services, medtech, tools & hcit conference

February 21, 2023

Bio-Techne and Cell Signaling Technology announce partnership to validate Simple Western antibodies

February 13, 2023

Bio-Techne releases second quarter fiscal 2023 results

February 1, 2023

Bio-Techne announces retirement, appointment of General Counsel

January 30, 2023

BIO-TECHNE LAUNCHES THE MauriceFlex™ SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS

January 25, 2023

Bio-Techne to host conference call on February 2, 2023, to announce second quarter 2023 financial results

January 16, 2023

Bio-Techne launches RNAscope Plus assay to advance gene therapy development

January 9, 2023

Calls in 2023

Decks in 2023